CEVA Inc (CEVA)

• Market cap: $614M
• 1 day: 0.35%
• 5 days: -8.38%
• 1 month: -19.21%
• 3 months: -19.44%
• 6 months: 7.62%
• Year to date: -19.44%
• 1 year: 11.93%
• 5 years: 4.56%
• 10 years: 21.17%
• Sector: Information Technology
• Industry: Computer Programming, Data Processing, Etc.

About: CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.

Employees: 383

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

177% more call options, than puts

Call options by funds: $1.57M | Put options by funds: $568K

29% more capital invested

Capital invested by funds: $502M [Q3] → $649M (+$147M) [Q4]

21% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 24

3% more funds holding

Funds holding: 158 [Q3] → 163 (+5) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

0.45% less ownership

Funds ownership: 87.69% [Q3] → 87.24% (-0.45%) [Q4]

18% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 57

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $40 56% upside
• Avg. target: $43 65% upside
• High target: $45 75% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Rosenblatt Kevin Cassidy 14% 1-year accuracy 11 / 77 met price target	75% upside $45	Buy Maintained	14 Feb 2025
Barclays Tavy Rosner 50% 1-year accuracy 6 / 12 met price target	56% upside $40	Overweight Maintained	14 Feb 2025